Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Jan 15;97(2):309–315. doi: 10.1172/JCI118417

Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells.

L Schandené 1, G F Del Prete 1, E Cogan 1, P Stordeur 1, A Crusiaux 1, B Kennes 1, S Romagnani 1, M Goldman 1
PMCID: PMC507019  PMID: 8567949

Abstract

The effects of recombinant IFN-alpha on the production of IL-5 by human CD4+ T cells were first analyzed on resting CD4+ T cells purified from normal PBMC and stimulated either with a combination of PMA and anti-CD28 mAb or anti-CD3 mAb cross-linked on B7-1/CD32-transfected mouse fibroblasts. We found that IFN-alpha profoundly inhibited in a dose-dependent manner IL-5 production by resting CD4+ T cells whereas IL-10 was upregulated in both systems. The addition of a neutralizing anti-IL-10 mAb to PMA and anti-CD28 mAb upregulated IL-5 production by resting CD4+ T cells but did not prevent IFN-alpha-induced IL-5 inhibition. We then analyzed the effect of IFN-alpha on the production of cytokines by differentiated type 2 helper (Th2) CD4+CD3- cells isolated from peripheral blood of two patients with the hypereosinophilic syndrome. In both cases, IFN-alpha markedly inhibited IL-5 production while it induced mild upregulation of IL-4 and IL-10. Finally, the inhibitory effect of IFN-alpha on IL-5 production was confirmed on a panel of Th2 and Th0 clones generated in vitro. In 2 out of 6 clones, IL-5 inhibition was associated with upregulation of IL-4 and IL-10. We conclude that IFN-alpha selectively downregulates IL-5 synthesis by human CD4+ T cells.

Full Text

The Full Text of this article is available as a PDF (220.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aman M. J., Rudolf G., Goldschmitt J., Aulitzky W. E., Lam C., Huber C., Peschel C. Type-I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells. Blood. 1993 Oct 15;82(8):2371–2378. [PubMed] [Google Scholar]
  2. Bohjanen P. R., Okajima M., Hodes R. J. Differential regulation of interleukin 4 and interleukin 5 gene expression: a comparison of T-cell gene induction by anti-CD3 antibody or by exogenous lymphokines. Proc Natl Acad Sci U S A. 1990 Jul;87(14):5283–5287. doi: 10.1073/pnas.87.14.5283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brinkmann V., Geiger T., Alkan S., Heusser C. H. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J Exp Med. 1993 Nov 1;178(5):1655–1663. doi: 10.1084/jem.178.5.1655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Broxmeyer H. E., Lu L., Platzer E., Feit C., Juliano L., Rubin B. Y. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol. 1983 Sep;131(3):1300–1305. [PubMed] [Google Scholar]
  5. Butterfield J. H., Gleich G. J. Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome. Ann Intern Med. 1994 Nov 1;121(9):648–653. doi: 10.7326/0003-4819-121-9-199411010-00003. [DOI] [PubMed] [Google Scholar]
  6. Coffman R. L., Seymour B. W., Hudak S., Jackson J., Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science. 1989 Jul 21;245(4915):308–310. doi: 10.1126/science.2787531. [DOI] [PubMed] [Google Scholar]
  7. Cogan E., Schandené L., Crusiaux A., Cochaux P., Velu T., Goldman M. Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med. 1994 Feb 24;330(8):535–538. doi: 10.1056/NEJM199402243300804. [DOI] [PubMed] [Google Scholar]
  8. Del Prete G. F., De Carli M., Mastromauro C., Biagiotti R., Macchia D., Falagiani P., Ricci M., Romagnani S. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest. 1991 Jul;88(1):346–350. doi: 10.1172/JCI115300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Del Prete G. Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy. Allergy. 1992 Oct;47(5):450–455. doi: 10.1111/j.1398-9995.1992.tb00662.x. [DOI] [PubMed] [Google Scholar]
  10. Demeure C. E., Wu C. Y., Shu U., Schneider P. V., Heusser C., Yssel H., Delespesse G. In vitro maturation of human neonatal CD4 T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine production. J Immunol. 1994 May 15;152(10):4775–4782. [PubMed] [Google Scholar]
  11. Finkelman F. D., Svetic A., Gresser I., Snapper C., Holmes J., Trotta P. P., Katona I. M., Gause W. C. Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice. J Exp Med. 1991 Nov 1;174(5):1179–1188. doi: 10.1084/jem.174.5.1179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gleich G. J., Adolphson C. R., Leiferman K. M. The biology of the eosinophilic leukocyte. Annu Rev Med. 1993;44:85–101. doi: 10.1146/annurev.me.44.020193.000505. [DOI] [PubMed] [Google Scholar]
  13. Gruschwitz M. S., Peters K. P., Heese A., Stosiek N., Koch H. U., Hornstein O. P. Effects of interferon-alpha-2b on the clinical course, inflammatory skin infiltrates and peripheral blood lymphocytes in patients with severe atopic eczema. Int Arch Allergy Immunol. 1993;101(1):20–30. doi: 10.1159/000236494. [DOI] [PubMed] [Google Scholar]
  14. Kapsenberg M. L., Wierenga E. A., Bos J. D., Jansen H. M. Functional subsets of allergen-reactive human CD4+ T cells. Immunol Today. 1991 Nov;12(11):392–395. doi: 10.1016/0167-5699(91)90137-I. [DOI] [PubMed] [Google Scholar]
  15. Kennedy M. K., Torrance D. S., Picha K. S., Mohler K. M. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol. 1992 Oct 1;149(7):2496–2505. [PubMed] [Google Scholar]
  16. Kühn R., Löhler J., Rennick D., Rajewsky K., Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993 Oct 22;75(2):263–274. doi: 10.1016/0092-8674(93)80068-p. [DOI] [PubMed] [Google Scholar]
  17. Langer J. A., Pestka S. Interferon receptors. Immunol Today. 1988 Dec;9(12):393–400. doi: 10.1016/0167-5699(88)91241-8. [DOI] [PubMed] [Google Scholar]
  18. MacKie R. M. Interferon-alpha for atopic dermatitis. Lancet. 1990 May 26;335(8700):1282–1283. doi: 10.1016/0140-6736(90)91348-e. [DOI] [PubMed] [Google Scholar]
  19. Moore K. W., O'Garra A., de Waal Malefyt R., Vieira P., Mosmann T. R. Interleukin-10. Annu Rev Immunol. 1993;11:165–190. doi: 10.1146/annurev.iy.11.040193.001121. [DOI] [PubMed] [Google Scholar]
  20. Mosmann T. R., Coffman R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145–173. doi: 10.1146/annurev.iy.07.040189.001045. [DOI] [PubMed] [Google Scholar]
  21. Murphy P. T., Fennelly D. F., Stuart M., O'Donnell J. R. Alfa-interferon in a case of hypereosinophilic syndrome. Br J Haematol. 1990 Aug;75(4):619–620. doi: 10.1111/j.1365-2141.1990.tb07811.x. [DOI] [PubMed] [Google Scholar]
  22. Nakajima H., Nakao A., Watanabe Y., Yoshida S., Iwamoto I. IFN-alpha inhibits antigen-induced eosinophil and CD4+ T cell recruitment into tissue. J Immunol. 1994 Aug 1;153(3):1264–1270. [PubMed] [Google Scholar]
  23. Owen W. F., Rothenberg M. E., Petersen J., Weller P. F., Silberstein D., Sheffer A. L., Stevens R. L., Soberman R. J., Austen K. F. Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med. 1989 Jul 1;170(1):343–348. doi: 10.1084/jem.170.1.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Parronchi P., De Carli M., Manetti R., Simonelli C., Sampognaro S., Piccinni M. P., Macchia D., Maggi E., Del Prete G., Romagnani S. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J Immunol. 1992 Nov 1;149(9):2977–2983. [PubMed] [Google Scholar]
  25. Prin L., Plumas J., Gruart V., Loiseau S., Aldebert D., Ameisen J. C., Vermersch A., Fenaux P., Bletry O., Capron M. Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome. Blood. 1991 Nov 15;78(10):2626–2632. [PubMed] [Google Scholar]
  26. Robinson D. S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A. M., Corrigan C., Durham S. R., Kay A. B. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 1992 Jan 30;326(5):298–304. doi: 10.1056/NEJM199201303260504. [DOI] [PubMed] [Google Scholar]
  27. Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol Today. 1991 Aug;12(8):256–257. doi: 10.1016/0167-5699(91)90120-I. [DOI] [PubMed] [Google Scholar]
  28. Rook A. H., Kubin M., Cassin M., Vonderheid E. C., Vowels B. R., Wolfe J. T., Wolf S. F., Singh A., Trinchieri G., Lessin S. R. IL-12 reverses cytokine and immune abnormalities in Sezary syndrome. J Immunol. 1995 Feb 1;154(3):1491–1498. [PubMed] [Google Scholar]
  29. Sanderson C. J. Interleukin-5, eosinophils, and disease. Blood. 1992 Jun 15;79(12):3101–3109. [PubMed] [Google Scholar]
  30. Schandené L., Alonso-Vega C., Willems F., Gérard C., Delvaux A., Velu T., Devos R., de Boer M., Goldman M. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol. 1994 May 1;152(9):4368–4374. [PubMed] [Google Scholar]
  31. Schandené L., Ferster A., Mascart-Lemone F., Crusiaux A., Gérard C., Marchant A., Lybin M., Velu T., Sariban E., Goldman M. T helper type 2-like cells and therapeutic effects of interferon-gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur J Immunol. 1993 Jan;23(1):56–60. doi: 10.1002/eji.1830230110. [DOI] [PubMed] [Google Scholar]
  32. Schrezenmeier H., Thomé S. D., Tewald F., Fleischer B., Raghavachar A. Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome. Exp Hematol. 1993 Feb;21(2):358–365. [PubMed] [Google Scholar]
  33. Sher A., Coffman R. L., Hieny S., Scott P., Cheever A. W. Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Natl Acad Sci U S A. 1990 Jan;87(1):61–65. doi: 10.1073/pnas.87.1.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Tilg H., Mier J. W., Vogel W., Aulitzky W. E., Wiedermann C. J., Vannier E., Huber C., Dinarello C. A. Induction of circulating IL-1 receptor antagonist by IFN treatment. J Immunol. 1993 May 15;150(10):4687–4692. [PubMed] [Google Scholar]
  35. Vowels B. R., Lessin S. R., Cassin M., Jaworsky C., Benoit B., Wolfe J. T., Rook A. H. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol. 1994 Nov;103(5):669–673. doi: 10.1111/1523-1747.ep12398454. [DOI] [PubMed] [Google Scholar]
  36. Wierenga E. A., Backx B., Snoek M., Koenderman L., Kapsenberg M. L. Relative contributions of human types 1 and 2 T-helper cell-derived eosinophilotrophic cytokines to development of eosinophilia. Blood. 1993 Sep 1;82(5):1471–1479. [PubMed] [Google Scholar]
  37. Wirth H. P., Zala G., Meyenberger C., Jost R., Ammann R., Münch R. Alpha-Interferon-Therapie bei M. Crohn: erste klinische Erfahrungen. Schweiz Med Wochenschr. 1993 Jul 13;123(27-28):1384–1388. [PubMed] [Google Scholar]
  38. Zielinski R. M., Lawrence W. D. Interferon-alpha for the hypereosinophilic syndrome. Ann Intern Med. 1990 Nov 1;113(9):716–718. doi: 10.7326/0003-4819-113-9-716. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES